Taking NMDA antagonists every day can't be good for you in the long run.
This is an important question of course, and I must admit that taking something daily where nobody knows what the long-term consequences could be or how to help with withdrawal sometimes scares me.
After abrupt (forced) cessation of 40mg/d together with an opiate (antagonized by naloxone btw), cocaine, clonidine and venlafaxine I felt very tense, anxious and overexcited with intense headaches, it felt like being on the borderline to seizures but fortunately nothing happened and the next day I was put on low-dose lorazepam. Regarding the bunch of substances I was taking before it was no surprise to have a bad week of course and probably the long half life of memantine saved me from experiencing opiate w/d.
The over-excitation feeling did not fade even after ten days and the venlafaxine-related brain zaps on top of this made the fear of seizures very real. The over-excitation was real too since even with mirtazapine I just slept for 5 hours. So after I was discharged with all the substances seized and nothing seemed to help I got a prescription of memantine again. Within hours I felt huge relief. This made me fear of being dependent of memantine of course..
Now some months later I´m down on 20mg/d with no negatives. Also memantine has a relatively low affinity to the NMDA receptor which does not block it completely. Cognitive-wise I feel ambivalent. It might slow down some thought processes but overall it´s much lighter than many psychiatric medicines.
I think about tapering down to zero, while on the other side it has its solid positives on stabilizing mood and is synergetic with methylphenidate so I´d like to stay on a low dose. Also I felt really no cravings for opioids which I attribute to a large part to the memantine. Doctors throw around neuroleptics all day and they are known to be toxic on the long run, for example.
But any information about the long-term consequences of memantine is very welcome! Could the D2 agonism (possibly causing dopamine agonist related PAWS) be more problematic than the slight NMDA blockade in the end?